Showing results (1301-1310 of 1,887) with videos related to
Sort By:
Pageof 189
Plos One|August 26, 2014
Alcohol tax policy and related mortality. An age-period-cohort analysis of a rapidly developed Chinese population, 1981-2010Roger Y Chung, Jean H Kim, Benjamin H Yip, et al.Military Medicine|February 3, 2026
Pilonidal Disease: A Recent Decade of the Disease among Active Duty United States Military Service MembersDylan M Griffiths, Meg I Robinson, Amber L Dougherty, et al.Computer Methods and Programs in Biomedicine|November 14, 2022
Development of a multimodal machine-learning fusion model to non-invasively assess ileal Crohn's disease endoscopic activityItai Guez, Gili Focht, Mary-Louise C Greer, et al.Scientific Reports|December 15, 2022
Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapyAlexandra C Kendall, Suzanne M Pilkington, Jonathan R Wray, et al.Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Using Deep Learning to Automate Eosinophil Counting in Pediatric Ulcerative Colitis Histopathological ImagesJames Reigle, Oscar Lopez-Nunez, Erik Drysdale, et al.The Gerontologist|March 20, 2016
Age-Associated Skin Conditions and Diseases: Current Perspectives and Future OptionsUlrike Blume-Peytavi, Jan Kottner, Wolfram Sterry, et al.The British Journal of Dermatology|February 24, 2012
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectivesA D Burden, R B Warren, C E Kleyn, et al.Journal of American College Health : J of ACH|December 5, 2009
University binge drinking patterns and changes in patterns of alcohol consumption among chinese undergraduates in a Hong Kong universityJean H Kim, Karli W C Chan, Julie K W Chow, et al.American Journal of Clinical Dermatology|March 31, 2018
Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.American Journal of Clinical Dermatology|January 12, 2017
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.Pageof 189